|
 The US Food and Drug Administration (FDA) has approved the use of rifaximin (Xifaxan; Salix Pharmaceuticals Inc) to reduce risk for recurrence of overt hepatic encephalopathy (HE) in patients with advanced liver disease.
 Long-term marathon training and racing might not be as good for the heart as some runners think, a new study suggests . Researchers have shown that long-term marathon runners, those who have completed at least 25 marathons over the past 25 years, have increased coronary calcium and calcified plaque volume.
 Obesity and alcohol act together to increase the risk for liver disease in both men and women, according to the results of 2 prospective studies reported online in the March 11 issue of the BMJ.
Daily acyclovir therapy may not reduce the risk for HIV-1 transmission, according to the results of a randomized, placebo-controlled multicenter trial reported online in the January 20 issue of the New England Journal of Medicine.
|
|
|
Triple arterial bypass with two mammary graft and... 
Palliation for Hypoplastic Left Heart Syndrome Redmond Burke... 
.Review of these areas2 
.Nasopharynx 2 
